Respiratory syncytial virus (RSV) is the leading cause of infant hospitalizations in Canada, yet many otherwise healthy infants remain unprotected. This program equips primary care providers with the latest evidence and practical tools to close protection gaps. Through real-world case scenarios, clinicians will learn to identify missed opportunities for RSV immunization, apply a presumptive communication approach with caregivers, and implement effective clinic-level strategies to ensure every infant receives timely protection. Participants will leave prepared to confidently recommend and administer RSV prevention, helping reduce the burden of severe RSV disease in infants across Canada.
This program has received an unrestricted educational grant or in-kind support from Sanofi Canada.